(2-苯基哌啶-1-基)[4-(3'-(哌啶-1-羰基)-[1,1'-联苯]-4-基)-1H-1,2,3-三唑-1-基]甲酮
(2-Phenylpiperidin-1-yl)(4-(3'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone
产品编号 :
Cas No. :
| 包装规格 |
纯度 |
目录价 |
会员专享价 |
库存 |
数量 |
| 5mg |
99% |
|
|
询价 |
|
| 10mg |
99% |
|
|
询价 |
|
| 25mg |
99% |
|
|
询价 |
|
| 50mg |
99% |
|
|
询价 |
|
| 100mg |
99% |
|
|
询价 |
|
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No. |
1472640-86-0 |
中文名称 |
(2-苯基哌啶-1-基)[4-(3'-(哌啶-1-羰基)-[1,1'-联苯]-4-基)-1H-1,2,3-三唑-1-基]甲酮 |
英文名称 |
(2-Phenylpiperidin-1-yl)(4-(3'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone |
别名 |
KT185;Methanone, [4'-[1-[(2-phenyl-1-piperidinyl)carbonyl]-1H-1,2,3-triazol-4-yl][1,1'-biphenyl]-3-yl]-1-piperidinyl-;KT185 >=98% (HPLC);KT185,KT-185 |
标准英文名 |
(2-phenylpiperidin-1-yl)(4-(3'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone |
分子式 |
C32H33N5O2 |
分子量 |
519.65
|
精确分子量 |
519.26
|
SMILES |
O=C(N1CCCCC1)C2=CC=CC(C3=CC=C(C=C3)C4=CN(N=N4)C(N5CCCCC5C6=CC=CC=C6)=O)=C2 |
标准SMILES |
O=C(N1C=C(N=N1)C1C=CC(=CC=1)C1=CC(=CC=C1)C(=O)N1CCCCC1)N1CCCCC1C1C=CC=CC=1 |
用途 |
KT185 is an orally active, blood-brain barrier permeable, selective inhibitor of ABHD6, with an IC50 of 0.21 nM in Neuro2A cells. |
InChIKey |
SGQNTNACVSWXMA-UHFFFAOYSA-N |